Norway · Delayed Price · Currency is NOK Nordhealth AS Statistics
Total Valuation
Nordhealth AS has a market cap or net worth of NOK 1.91 billion. The enterprise value is 1.77 billion.
| Market Cap | 1.91B |
| Enterprise Value | 1.77B |
Important Dates
The last earnings date was Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Nordhealth AS has 78.90 million shares outstanding. The number of shares has decreased by -0.27% in one year.
| Current Share Class | 44.47M |
| Shares Outstanding | 78.90M |
| Shares Change (YoY) | -0.27% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 44.19% |
| Owned by Institutions (%) | 9.89% |
| Float | 42.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.17 |
| PB Ratio | 3.07 |
| P/TBV Ratio | 18.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.94 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.60
| Current Ratio | 1.60 |
| Quick Ratio | 1.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -136.21 |
Financial Efficiency
Return on equity (ROE) is -25.83% and return on invested capital (ROIC) is -35.20%.
| Return on Equity (ROE) | -25.83% |
| Return on Assets (ROA) | -12.63% |
| Return on Invested Capital (ROIC) | -35.20% |
| Return on Capital Employed (ROCE) | -27.39% |
| Weighted Average Cost of Capital (WACC) | 6.07% |
| Revenue Per Employee | 1.35M |
| Profits Per Employee | -402,759 |
| Employee Count | 457 |
| Asset Turnover | 0.71 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Nordhealth AS has paid 6.41 million in taxes.
| Income Tax | 6.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.88% in the last 52 weeks. The beta is 0.33, so Nordhealth AS's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -33.88% |
| 50-Day Moving Average | 23.74 |
| 200-Day Moving Average | 28.98 |
| Relative Strength Index (RSI) | 55.42 |
| Average Volume (20 Days) | 6,556 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nordhealth AS had revenue of NOK 601.42 million and -180.03 million in losses. Loss per share was -2.28.
| Revenue | 601.42M |
| Gross Profit | 141.74M |
| Operating Income | -171.10M |
| Pretax Income | -173.63M |
| Net Income | -180.03M |
| EBITDA | -118.93M |
| EBIT | -171.10M |
| Loss Per Share | -2.28 |
Balance Sheet
The company has 141.48 million in cash and no debt, with a net cash position of 141.48 million or 1.79 per share.
| Cash & Cash Equivalents | 141.48M |
| Total Debt | n/a |
| Net Cash | 141.48M |
| Net Cash Per Share | 1.79 |
| Equity (Book Value) | 622.86M |
| Book Value Per Share | 7.89 |
| Working Capital | 92.33M |
Cash Flow
In the last 12 months, operating cash flow was -27.15 million and capital expenditures -55.49 million, giving a free cash flow of -82.64 million.
| Operating Cash Flow | -27.15M |
| Capital Expenditures | -55.49M |
| Depreciation & Amortization | 50.24M |
| Net Borrowing | n/a |
| Free Cash Flow | -82.64M |
| FCF Per Share | -1.05 |
Margins
Gross margin is 23.57%, with operating and profit margins of -28.45% and -29.93%.
| Gross Margin | 23.57% |
| Operating Margin | -28.45% |
| Pretax Margin | -28.87% |
| Profit Margin | -29.93% |
| EBITDA Margin | -19.78% |
| EBIT Margin | -28.45% |
| FCF Margin | n/a |
Dividends & Yields
Nordhealth AS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.27% |
| Shareholder Yield | 0.27% |
| Earnings Yield | -9.43% |
| FCF Yield | -4.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Nordhealth AS has an Altman Z-Score of 8.78 and a Piotroski F-Score of 2.
| Altman Z-Score | 8.78 |
| Piotroski F-Score | 2 |